Pearl Cohen represented Immune Pharmaceuticals Inc. in its transaction to acquire the rights to Ceplene from Meda A.B., now part of Mylan, a global healthcare company….
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
